|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 28, 2017 ) Vasculitis is an autoimmune disorder that causes inflammation of the blood vessels. The body's immune system attacks the blood vessels, which results in inflammation. When this inflammation occurs, the walls of the affected blood vessels get thicker and the passages through which the blood flows get narrower, which reduces the amount of blood and oxygen delivered to vital organs.
Publisher's analysts forecast the global vasculitis treatment market to grow at a CAGR of 4.20 % during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-vasculitis-treatment-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global vasculitis treatment market for 2017-2021. To calculate the market size, the report considers the sales from the drugs.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Vasculitis Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-Bristol-Myers Squibb
-CELGENE
-F. Hoffmann-La Roche
-GlaxoSmithKline
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001847143/sample .
Other prominent vendors
-Ablynx
-AB SCIENCES
-Acorda Therapeutics
-Alder Biopharmaceuticals
-Antares Pharma
-Astellas Pharma
-AstraZeneca
-Baxter
-Boehringer Ingelhein
-Can-Fite BioPharma
-Celltrion
-ChemoCentryx
-Coherus BioSciences
-Daiichi Sankyo
-Eisai
-Eli Lilly
-Gilead Sciences
-Hospira
-Idera
-Immunomedics
-ImmuPharma
-Incyte
-Invion
-KaloBios Pharmaceuticals
-Lexicon Pharmaceuticals
-Merck
-MedImmune
-Morphotek
-Novo Nordisk
-Novartis
-Opexa Therapeutics
-Principia
-Regeneron
-Sandoz
-Sanofi
-Santarus
-Takeda
-UCB
-Vaccinex
-Vertex Pharmaceuticals
-Vitae Pharmaceuticals
Market driver
-Promising pipeline
-For a full, detailed list, view our report
Market challenge
-Loss of patent exclusivity of branded therapies
-For a full, detailed list, view our report
Market trend
-Strategic alliances
-For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001847143/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
